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Introduction: Human ear reconstruction is recognized as the emblematic enterprise in tissue engineering.
Up to now, it has failed to reach human applications requiring appropriate tissue complexity along with
an accessible vascular tree. We hereby propose a new method to process human auricles in order to pro-
vide a poorly immunogenic, complex and vascularized ear graft scaffold.
Methods: 12 human ears with their vascular pedicles were procured. Perfusion-decellularization was
applied using a SDS/polar solvent protocol. Cell and antigen removal was examined by histology and
DNA was quantified. Preservation of the extracellular matrix (ECM) was assessed by conventional and
3D-histology, proteins and cytokines quantifications. Biocompatibility was assessed by implantation in
rats for up to 60 days. Adipose-derived stem cells seeding was conducted on scaffold samples and with
human aortic endothelial cells whole graft seeding in a perfusion-bioreactor.
Results: Histology confirmed cell and antigen clearance. DNA reductionwas 97.3%. ECMstructure and com-
positionwere preserved. Implanted scaffolds were tolerated in vivo, with acceptable inflammation, remodel-
ing, and anti-donor antibody formation. Seeding experiments demonstrated cell engraftment and viability.
Conclusions: Vascularized and complex auricular scaffolds can be obtained fromhuman source to provide a
platform for further functional auricular tissue engineered constructs, hence providing an ideal road to the
vascularized composite tissue engineering approach.
Statement of Significance
The ear is emblematic in the biofabrication of tissues and organs. Current regenerative medicine strategies,
with matrix from donor tissues or 3D-printed, didn’t reach any application for reconstruction, because
critically missing a vascular tree for perfusion and transplantation. We previously described the produc-
tion of vascularized and cell-compatible scaffolds, from porcine ear grafts. In this study, we ---- applied
findings directly to human auricles harvested from postmortem donors, providing a perfusablematrix that
retains the ear’s original complexity and hosts new viable cells after seeding. This approach unlocks the
ability to achieve an auricular tissue engineering approach, associated with possible clinical translation.
 2018 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CCBY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/)..taddeo@
caroline.
uvain.be
uvain.be
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Reconstruction of sizable auricular defects represents an endur-
ing challenge in the field of plastic surgery, with variable clinical
results despite extensive approaches and experimentation. Con-
ventional autologous techniques [1–4] produce donor site morbid-
ity and are limited by surgeon experience and expertise. The use of
prosthetic cartilage implants has been reported, however the risk
of extrusion has limited clinical applicability [5]. Vascularized
Composite tissue Allotransplantation (VCA), whereby cadaver auri-
cles are harvested and implanted into a recipient, are not available
for single subunit reconstruction, since immunosuppressive (IS)
treatment is not acceptable for such a small, non-life saving trans-
plant [6]. In theory, tissue engineered (TE) autologous auricular
implants may be able to overcome the limitations of current tech-
niques [7–9], unfortunately the move from bench to bedside has
yet to be achieved. Barriers to the success of TE auricles include
the challenge of reproducing the biological complexity of human
tissue along with the challenge of creating and accessing a vascular
tree necessary for sustainment of seeded cells and implantation
into a recipient. The perfusion-decellularization technique, as pre-
viously described in organs [10–14] and composite tissues [15–17],
may represent the ‘holy grail’ of immunosuppression-free auricular
transplantation. The basics of this technique involve circulating a
mild detergent through a harvested organ/tissue via the native vas-
cular system with the goal of removing cellular components, thus
creating an extracellular matrix (ECM) scaffold retaining original
tissue architecture and properties. The ECM scaffold could then
be repopulated with autologous cells that would lead to a biologi-
cal identity reassignment and immune tolerance once implanted.
This technology appears ideally suited for the creation of a clini-
cally useful bioengineered auricle. We previously reported the
application of the perfusion-decellularization technique in porcine
ear and human face models, with successful graft decellularization,
preservation and accessibility of the vascular tree, suitable for
repopulation with new cells and allocompatibility [18,19]. We
hypothesized that this technology can be applied to human ear
grafts. We hereby propose a method to process cadaveric human
auricles, in order to provide a poorly immunogenic, complex and
vascularized ear graft scaffold. Indeed, the relatively robust nature
of composite tissues to post-mortem degradation could allow suc-
cessful transplant processing, defining the new auricular synthesis
approach of Vascularized Composite tissue Engineering (VCE).2. Materials and methods
2.1. Specimens
Twelve ear grafts were harvested from eight human cadaveric
donors at the Université catholique de Louvain human anatomy
department (Brussels, Belgium). Prior to passing, all donors had
consented to research and teaching on their body. Donors were
aged 68–104 years at the time of death. Bodies were preserved at
4 C for 1–4 days prior to graft procurement. All animal experi-
ments were approved by the Université catholique de Louvain Ani-
mal Ethics Committee and following the EU Directive 2010/63/EU
for animal experiments.2.2. Ear graft procurement and perfusion-decellularization
According to previously described surgical protocol [20,21], ears
were harvested with their corresponding vascular and nervous
pedicles. Briefly, a peri-auricular incision was made within 1 cm
around auricular implantation and continued to the temporal and
cervical regions. In the cervical region, the common carotid artery,external carotid artery, posterior auricular artery (PAA), proximal
superficial temporal artery (STA), external jugular vein and great
auricular nerve were isolated. All other arterial branches and collat-
erals were ligated. After temporal incision, distal STA and vein were
identified and dissected distally to frontal and parietal branches.
Pre-auricular STA dissection and exposure was completed through
the parotid gland. Superficial temporalis fascia was incised circum-
ferentially, then elevated by blunt subfascial undermining down to
the zygomatic arch of the temporal bone aiming to reach the exter-
nal acoustic meatus and posteriorly, to the external aspect of the
mastoid process. During this retrograde dissection, the PAA was
protected. Finally, the ear was completely elevated, along with its
pedicle. Contralateral ear was either harvested identically or simply
explanted as control. A luer was inserted in the arterial pedicle for
heparinized saline (15 UI/ml) irrigation of the graft. This solution
was infused until clear return was identified, in veins left free. Com-
plementary vascular control was performedwith either suture liga-
tion or microclips. Remaining parotid tissue was excised then each
ear was weighted. The arterial catheter was then connected to a
Masterflex L/S peristaltic pump with L/S easy load pump head
and L/S 16G tubing (Cole-Palmer Instrument Co, Vernon Hills, IL,
USA) after final immersion in a 1L glass jar filled with the same
solution as perfused. Perfusion-decellularization sequence, in an
open circuit fashion, followed eight steps: (1) 1000 ml of hep-
arinized saline (15UI/ml), containing 10 lM adenosine (Sigma-
Aldrich, St. Louis, MO), 4 C; 1% sodium dodecyl sulfate (SDS,
VWR, Radnor, PA) in deionized water (DIW) was perfused for 88
h (36500 ml), room temperature (RT). This treatments leads to
epidermolysis and bullae formation, tissue bleaching and edema
formation, while shape is preserved; (3) DIW was then perfused
for 3 h (1200 ml), RT; (4) Triton-X 100 1% (VWR) in DIW for 25 h
(10000 ml), RT; (5) Phosphate buffered saline (PBS) for 38 h
(16000 ml), RT; (6) Polar solvent step (100% 2-propanol , VWR),
as previously described [22,23], whereby the flap was perfused
for 4 h (1000 ml), until critical increase of vascular resistances, then
transferred to a stirring bath of polar solvent overnight at RT, chan-
ged once, then rinsed in DIW bath for 2 h, and finally perfused with
PBS for 30 h (16000 ml). This treatment removes oil from adipose
tissue layer; (7) Type I Bovine DNAse (Roche I, Sigma), 50 UI/ml
in PBS with 203.3 M magnesium chloride (Sigma), for 6 h (900
ml), 37 C; (8) final wash of the auricle with PBS for 12 h (4500
ml), RT. For all steps flow rate was set between 6 and 8 ml/min,
in order to observe a mean arterial pressure (MAP) under 80
mmHg, with exception of DNAse 2 ml/min perfusion. Decellular-
ized human ears (HE-ECM) were stored at 4 C in PBS. Before tissue
analysis, each HE-ECM was weighted, examined for epidermis and
hair remnants, bleaching and morphology.
2.3. Arterial pressure monitoring
During all steps of perfusion-decellularization, with exception
of polar solvent perfusion, MAP was recorded with a central line
connected to a Datex-Ohmeda S/5 anesthesia monitor and M-
Prestin module (GE Healthcare Life Sciences, Chicago, IL, USA) for
a selected pump inflow. A MAP profile was established for a con-
stant flow of 8 ml/min.
2.4. Fluoroscopic vascular assessment
Contrast agent (Visipaque, GE Healthcare) mixed with normal
saline (1:2) was injected in the arterial pedicle by a constant man-
ual syringe pressure, for a HE-ECM scaffold compared to a native
ear graft. Image acquisition was performed with a Powermobil C-
Arm (Siemens, Munich, Germany). Images were exported in
DICOM format and visualized with Osirix software (Pixmeo, Ber-
nex, Switzerland).
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Paraffin-embedding
Tissues were fixed in 4% formalin for 24 h, transferred in
successive toluene and alcohol baths prior to dehydration, then
embedded in paraffin and sectioned into 5 lm slices.
Histological staining
Sections were deparaffinized and rehydrated. We used
hematoxylin and eosin (H&E), Masson’s trichrome (MT), alcian
blue and safranin O stains according to standard protocols. Miller’s
elastin/alcian blue/sirius red stains were also performed as
described [24] in order to stain elastic fibers (purple), sulfated
glycosaminoglycans (GAGs) (blue) and collagen (red).
IHC
After deparaffinization, slides were subjected to antigen retrie-
val by heating at 98 C for 60 min in 10 mM citrate buffer, at pH
5.7. Endogenous peroxidases were inhibited using 1% H2O2 and
non-specific antigenic sites were neutralized with 1:50 goat serum.
Samples were incubated at 4 C overnight, using the primary
antibodies: anti-MHC type I + HLA A + HLA B (ab134189, 1:200,
Abcam, Cambridge, UK) and anti-CD31 (ab28364, 1:50, Abcam).
Next, the sections were incubated with 1:50 biotinylated
secondary antibody, stained with streptavidin-HRP (Sigma) and
3,30-diaminobenzidine (DAB) peroxidase substrate (Vector labora-
tories, Burlingame, Ca, USA), followed by counterstaining in
Mayer’s hematoxylin for 1 min, dehydration in alcohol and toluene
baths and finally mounting with Entellan mounting medium. PBS
containing 1% bovine serum albumin (BSA) was used to rinse
sections after each step.
IF
Deparaffinized, formalin-fixed sections were quenched with
NaBH4 (1:100), then subjected to antigen retrieval by heating at
98 C for 60 min in 10 mM citrate buffer, pH 5.7. Samples were
incubated at 4 C overnight with the following primary antibodies:
anti-type I collagen (ab34710, 1:250, Abcam), anti-type II collagen
(ab34712, 1:200, Abcam) and anti-type IV collagen (ab6586, 1:500,
Abcam). Neutralization of nonspecific sites was done with PBS con-
taining 5%BSA. For fluorescence staining, secondary antibody
labeled with Alexa Fluor 488 (goat anti-Rabbit or anti-mouse IgG,
1:300, ThermoFisher Scientific, Whaltam, MA), was used and the
nuclei were stained with 40-6-diamindino-2-phenyl-indole (DAPI,
1:1000) and mounted with DAKO fluorescent mounting medium
(Agilent, Santa Clara, CA, USA).
Lipid droplet evaluation on frozen sections
Tissue-Tek O.C.T. Compound (Sakura Finetek, Alphen aan den
Rijn, The Netherlands) embedded biopsies were cut on a Microm
HM 560 cryostat (ThermoFisher). Sections were cut to 5 lm
thickness and processed for the staining. For type IV Sudan (Sigma)
staining, sections were fixed for 10 min in 4% formaldehyde
directly after thawing, washed, incubated for 30 min in a Sudan
IV saturated solution, washed and mounted.
Histology and IHC sections were digitalized at 40 magnifica-
tion with a SCN400 slide scanner (Leica, Wetzlar, Germany) and
visualized using Digital Image Hub (Leica Biosystems, Dublin,
Ireland). Images of IF sections were acquired on a Zeiss
AxioImager.z1fluorescence microscope (Zeiss).
2.6. 3D-histology serial reconstruction and analysis
Full-thickness biopsies were taken from a native ear and a
HE-ECM graft. For each sample, 50 serial sections of 5 mm thickness
were prepared with Miller’s elastin/alcian blue/sirius red stains.Slides were scanned using the SCN400 slide scanner (Leica) with
a 40 objective. Damaged sections were discarded after visual
examination (2–3 sections per sample) and 3D-reconstruction
was performed using the HeteroGenius MIM 3D Pathology
add-on (HeteroGenius Ltd, Leeds, UK) with 4 levels of non-rigid
alignment (1.25, 2.5, 5 and 10) and a final B-Spline size of
12  12 mm, subsequent to automatic rigid alignment of sections
performed at 1.25. Whole sample 3-D visualization of original
data (1000  1000  50 voxels) was produced, with a total vol-
ume of 7.61 mm3 and 8.21 mm3 in the native ear and HE-ECM graft
samples respectively. Subvolume analysis data, defined by vol-
umes of interest in the cartilage, skin and connective tissue, from
both native and decellularized samples, was annotated manually
on a single slide, using a box of approximately 1  1  0.25 mm.
Animated Graphics Interchange Format (GIF) images of the whole
stack were produced by exporting the aligned stack volumes from
HeteroGenius MIM and using ImageJ software [25] for volume ren-
dered examples.
Quantitative analysis of porosity was performed on tissue sam-
ples using the HeteroGenius MIM Colour Analysis add-on. A 3-class
(collagen, elastin and background) probabilistic model was built by
manually labelling examples of each class. Pixel counting for each
class was performed for a single annotated sub-region per image,
by classifying a pixel as belonging to the class if the probability
of class membership was 0.75 or larger (‘‘QuantifyByColour” anal-
ysis method). Annotation of the tissue region was performed auto-
matically at 0.625 resolution, which uses a greyscale threshold
(value = 200), plus morphology, hole filling and boundary tracing
to annotate tissue pieces with a Bezier curve. Porosity was
obtained by the ratio between non-stained and stained volumes
between a native and a decellularized serial-sectioned samples.
Additionally, annotations excluding the cartilage were produced
manually for a subset of 2 images per sample.
2.7. Scanning electron microscopy (SEM)
Native and decellularized biopsies were fixed with 2.5% glu-
taraldehyde overnight at 4 C. Samples were then washed with
PBS and gradually dehydrated by successive immersion in increas-
ing concentrations of ethanol for 15 min each. Before SEM imaging,
tissues were critical-point dried and coated with an 8-nm gold
layer. SEM measurements were performed at 15 keV. Samples
were observed with a field-emission scanning electron microscope
(JSM-7600F, Jeol, Akishima, Tokyo, Japan) according to standard
protocols.
2.8. DNA quantification
DNA of skin (n = 6), fat (n = 4) and cartilage (n = 3) samples from
native ear (n = 3) and HE-ECM (n = 3) was extracted, with DNeasy
Blood & Tissue Kit (Qiagen, Hilden, Germany), processing up to
25 mg biopsies. Briefly, tissues were incubated overnight at 56 C
with proteinase K (40 mAU/mg protein) solution. After adding buf-
fer and ethanol, the mixture was transferred to a spin column filled
with buffers and repeated elution was performed. Extracted DNA
content was assessed by Quant-itTM Picrogreen dsDNA assay kit
(ThermoFischer Scientific), according to manufacturer’s protocol.
Final value was expressed in ng DNA per mg tissue wet weight.
2.9. ECM protein quantification
Biopsies of skin (n = 6), fat (n = 4) and cartilage (n = 3) samples
from native (n = 3) and decellularized (n = 3) different ear grafts
were used. Collagen content was evaluated using a Chondrex
hydroxyproline assay kit (Chondrex, Inc., Redmond, WA) according
to manufacturer’s protocol. Briefly, samples were hydrolyzed in
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yproline standards. Chloramine-T was added to solution from sam-
ples and standards, then incubated 20 min at room temperature.
DMAB was added to standards and samples solutions, then incu-
bated at 60 C. Absorbance was read at 570 nm. GAGs content was
evaluated using the Blyscan Sulfated-GAG assay kit (Biocolor
LTD, Carrickfergus, Northern Ireland) according to manufacturer’s
recommendations; samples extraction was proceeded with papain
overnight at 65 C. After centrifugation, supernatant was collected
and color reactant was added to precipitate S-GAGs, followed by
repeated centrifugation until dissociation was completed. Standard
was bovine tracheal chondroitin 4- sulfate. Absorbance was read at
630 nm. Elastin content was measured with the Fast Elastin Assay
kit (Biocolor) according to manufacturer’s recommendations.
0.25 M oxalic acid was added to samples, and digested for one hour
at 100 C before supernatant collection. This extraction was
repeated two times for skin and fat and three times for cartilage
and muscle. Final extraction volume was mixed with equal reac-
tant volume for elastin precipitation until complete elastin diges-
tion and centrifuged. Colored reactant was added in the
remaining solution, stirred and centrifuged prior to supernatant
elimination. Standard was a high molecular weight fraction of a-
elastin prepared from bovine neck ligament elastin in oxalic acid
Absorbance was read at 510 nm. All results were expressed as
mg/mg wet weight.
2.10. Mechanical properties
We used an Instron-5666 universal testing machine (Instron
Corporation) for all experiments. Ball burst tests were performed
to determine the stiffness of the cartilage. A 4-mm diameter steel
ball with 1 mm/min loading rate, and a 100 N load cell, was applied
to decellularized (n = 5) and native (n = 5) disc samples each from a
different donor, clamped in 5-mm diameter O-rings. Endpoint was
the maximum force. Stiffness was expressed as the ratio between
the maximum force and the corresponding crosshead displace-
ment. Values were divided by sample thickness and expressed as
N/mm.
Tensile tests were performed to determine the stress–strain
response of native (n = 4) and decellularized (n = 6) skin samples,
originated from different donors. Rectangular cross section sam-
ples were submitted to a tensile load with a 1 mm/min crosshead
speed and a 20 mm initial grip distance.
2.11. Cytokines quantification
Protein extraction
Skin, cartilage and fat tissue biopsies were collected from native
(n = 4) and decellularized ear grafts (n = 3). Samples were kept at
4 C until processing. Biopsies were weighed on an analytical scale
and cut into small pieces with a surgical knife. The pieces were
transferred into M tubes (Miltenyi Biotec GmbH, Bergisch Glad-
bach, Germany) containing RIPA buffer (50 mM Tris-HCl, pH 8.0,
with 150 mM sodium chloride, 1.0% Igepal CA-630 (NP40), 0.5%
sodium deoxy cholate and 0.1% sodium dodecyl sulfate) laced with
protease inhibitor cocktail (P8340, 1:100, SIGMA). M tubes were
promptly inverted and put on a gentle MACS Dissociator (Miltenyi
Biotec GmbH), then homogenized using the program specific for
protein extraction. After termination of the program, homogenates
were incubated on ice and underwent sonication. After a short spin
down, the supernatant was transferred to smaller tubes for cen-
trifugation at 130000 rpm for 1 h at 4 C. Again, the supernatant
was transferred to a new tube for further analysis. For protein
quantification, a classical Bicinchoninic acid (BCA) assay was per-
formed. A bovine serum albumin standard (2.0 mg/ml in 0.9%
aqueous NaCl containing sodium azide, 23209, Thermo Fisher Sci-entific) was prepared and transferred to a flat transparent 96-well
plate (Thermo Fisher Scientific). 5 ll of sample were added to the
wells and the assay was performed according to the DC Protein
Assay kit instructions (Bio-Rad, Hercules, CA, USA). The OD was
measured at 750 nm on a plate reader (Infinite M1000 PRO) and
interpolated by Prism 7 (GraphPad Software, La Jolla, CA, USA).
Cytokine measurement
Protein levels of 42 different cytokines were measured by Bio-
Plex multiplex immunoassays. The Bio-Plex Pro Human Chemo-
kine 40-Plex Panel (Bio-Rad) and the Bio-Plex Pro TGF-b 3-Plex
kit (Bio-Rad) were used to analyze the supernatants of the protein
extraction (above) and run on a FLEXMAP 3D system (Luminex,
Austin, CA, USA). The procedure was performed based on the orig-
inal manufacturer instruction manual. Growth factor content was
normalized to the mass of starting tissue and expressed as pg of
analyte per mg of tissue. After log2 transformation, concentrations
above or below the limit of detection were eliminated from the
analysis.
2.12. In vivo biocompatibility study
16 adult Wistar rats (all females, mean weight 208 ± 15 g) were
implanted subcutaneously with 2 biopsies, helix and lobe of
approximately 7  7  3 mm, from either native ear (n = 8) or
HE-ECM (n = 8), previously sterilized by 0.1% peracetic acid
(PCA). Samples came from three different donors in each group
(control versus decellularized). Within each group, we used the
same three different donors for each period of sacrifice (day 15,
day 30, day 60 – with exception of this last group involving only
two different donors. General anesthesia was performed using
intra-peritoneal injection of 50 mg/ml Ketamine with 20 mg/ml
Xylazin in saline. After disinfection, a median incision was per-
formed on the abdomen and two subcutaneous pockets were cre-
ated. For serum collection, 1 ml blood puncture was performed at
time of implantation and sacrifice; collected blood was then cen-
trifuged 15 min at 3000 rpm, and serum preserved at 80 C.
Euthanasia was performed at postoperative day (POD)15 (n = 6),
POD30 (n = 6) and POD60 (n = 4); then implants were retrieved,
paraffin-embedded, sectioned and stained with H&E, MT, anti-
CD68 (ab31360, Abcam) and anti-CD3 (ab16669) with IHC. For
inflammatory and lymphocytic quantification, CD68- and CD3-
stained sections were digitalized with the slide scanner and ana-
lyzed using the image analysis tool (Author version 6.6.3, Visio-
pharm, Hørsholm, Denmark). The implant in each section was
delineated manually and care was taken to exclude tissue folds
and artefacts from the analysis. CD68- and CD3-positive pixels
were then detected within the previously delineated tissue at high
resolution (20) using a classification based on image feature
highlighting the DAB staining (HDAB-DAB matrix of the software).
Threshold was adjusted on representative stained vs non-stained
tissue areas. The results were expressed as CD68- and CD3-
stained area percentages and calculated as-stained area/total tis-
sue area  100. The parameters were kept constant for all slides.
Detection of anti-donor alloantibody (IgG) by flow cytometry
Human peripheral blood mononucleated cells (PBMC), freshly
taken from a healthy donor, were incubated with recipient serum
for 30 min at room temperature. Before incubation, the serum
was decomplemented for 30 min at 56 C. After washing with
fluorescence-activated cell sorting buffer (Hanks balanced salt
solution – HBSS – containing 0.5% fetal bovine serum and 0.1%
sodium azide), saturating amounts of Alexa Fluor 488 goat anti-
rat IgG polyclonal antibody (Thermo Fisher Scientific, Merelbeke,
Belgium) was added and incubated for 30 min at room tempera-
ture, then washed twice. Each analysis included the appropriate
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specific reaction. Cells were acquired and analyzed with BD
FACSCalibur (BD Bioscience Benelux NV, Erembodegem, Belgium)
driven by CellQuest Pro software (BD Bioscience). A positive reac-
tion was defined as a shift of more than 10-channels in mean flu-
orescence intensity when testing donor lymphocytes with post-
transplantation (Day 15, 30 and 60) serum and comparing with
pre-transplant serum (Day 0).
2.13. Scaffold seeding with rodent adipose-derived stem cells
Rat Adipose-derived stem cells (rASCs)
rASCs were isolated as previously reported [26]: briefly, we
retrieved fresh inguinal fat from one adult rat, right after euthana-
sia for other experiments. Fat was digested with type II collagenase
(LS004176, Worthington, Lakewood, NJ, USA), reconstituted in
HBSS, and incubated for 1 h at 37 C with continuous agitation
for 60 min. After digestion, the collagenase was inactivated in
Dulbecco’s Modified Eagle’s Medium (DMEM, Westburg, Leusden,
The Netherlands) supplemented with 10% FBS, 2 mM L-glutamine,
penicillin 100 U/mL, and streptomycin 100 mg/mL. Collected tissue
was centrifuged for 10min at 1500 rpm, at room temperature. The
supernatant was aspirated and cells pellet was suspended with
DMEM with 10% FBS, 2 mM L-glutamine, penicillin 100 U/mL, and
streptomycin 100 mg/mL. After filtration through a 500-mm mesh
screen, the collected tissue was centrifuged for 10 min at 1500
rpm, at room temperature and the pellet was suspended in prolifer-
ation medium and identified as the stromal vascular fraction (SVF).
After 24–48 h of incubation at 37 C in 5% CO2, the cultures were
washed with PBS and maintained in proliferation medium, contain-
ing DMEMwith 4.5 g/L glucose w/o L-Glutamine supplemented with
10% of FBS, 1% of P/S and 1% of Glutamine and trypsinized when
reaching 80% confluence, up to 4 passages.
Scaffold sample seeding
Decellularized HE-ECM samples (n = 9), from external carotid
artery pedicle (D-Artery, n = 2), dorsal skin (D-Skin, n = 2) and helix
full-thickness (D-FT, n = 4) biopsies, were sterilized: briefly, 0.1%
PCA (Sigma) was prepared with DIW, and sterilized with a filtra-
tion unit. Samples were then washed overnight in PCA, using an
orbital stirrer. Samples were then rinsed with DIW and repeated
PBS washes on orbital-shaker, and finally preserved in sterile
PBS/AA. Scaffolds were positioned in a 24-well plate, then impreg-
nated with supplemented DMEM (10% of FBS, 1% of P/S and 1% of
Glutamine). rASCs were seeded at a density of 3.6x104 cells/ cm2
on each scaffold. All seeded HE-ECM were then placed in a CO2
incubator, and cultivated under standard conditions. Medium
was changed every 48 h for 14 days. At retrieval, biopsies were
first treated as whole-mounts with vital staining then Vybrant
MTT (4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bro-
mide) Cell Proliferation Assay Kit (Life Technologies) was used,
mixing 12 mM MTT with PBS. Next, specimens were incubated
with scaffold for 4 h at 37 C observed under a binocular micro-
scope, and with Live/Dead Viability/Cytotoxicity Kit (Life Tech-
nologies, L3224), incubating 2 mM ethidium homodimer and 4
mM calcein-AM with samples for 40 min at room temperature.
The rest of the constructs were paraffin-embedded, sectioned
and stained with H&E.
2.14. Bioreactor whole-graft human aortic endothelial cells (HAEC)
seeding
Scaffold preparation
A whole HE-ECM graft was sterilized using 0.1% PCA protocol of
alternating bath-stirring and perfusion, under sterile conditions, as
previously described [18]. The HE-ECM was then mounted in asterile perfusion-bioreactor, in closed circuit with the arterial pedi-
cle connected to the tubing and the veins left free in the jar. The
perfusion chamber was filled with 900 ml DMEM and graft condi-
tioned for 2 h with perfusion set at 5 ml/min, in a CO2 incubator,
set at 37 C and 5%CO2.
HAEC isolation and culture
Purchased HAEC ((304-05A, Sigma-Aldrich) were cultivated on
0.2% gelatin (Sigma G1393), with Endothelial Cell Growth Medium
MV2 (Bio-Connect, Toronto, Canada), changed twice a week, and
cells amplified 6 times once a week (standard passage) until
passage four.
Bioreactor whole-scaffold vascular seeding and culture
After scaffold immersion in 500 ml Endothelial Cell Growth
Medium MV2, 30x106 HAEC suspended in 7 ml medium were
slowly injected through the arterial line. After a four-hours static
period, to allow endothelial cell attachment, the perfusion flow
was restarted at 2 ml/min overnight, then increased to 6 ml/min.
After 48 h, the culture was stopped; biopsies were processed for
Live/Dead, MTT and CD31 IHC stainings.
2.15. Statistical analysis
Graphic presentation and statistical analysis was performed on
Prism 7 (GraphPad Software). For GAGs, elastin and collagen con-
tent, unpaired student t-tests were performed between native
and decellularized ear samples. For cytokines, two-sample t-tests
with Benjamini, Krieger and Yekutieli correction were performed
to quantitatively compare their abundance in native and decellu-
larized tissues. One-way ANOVA with post-hoc Tukey’s multiple
comparison correction was used to compare the relative preserva-
tion of the different cytokine groups within the analyzed tissues.
Data are presented as mean ± SEM for all analysis with exception
of cytokines quantification expressed as mean ± SD. P < 0.05 was
considered statistically significant.3. Results
3.1. Perfusion-decellularization
Blistering was observed within the first 12 h of SDS perfusion,
first affecting the posterior surface followed by the anterior surface
of the graft. The blisters evolved into large bullae which led to
complete epidermis removal (Fig. 1A and B). After completion of
the Triton-X step, a yellowish aspect of the adipose tissue
remained, demonstrating scattered oil cysts. Adipose tissue was
satisfyingly treated after the supplementary 2-propanol step, as
confirmed by macroscopic observation and type IV Sudan staining
(Fig. 1C and D). After the final PBS step, the cartilage layer retained
the original auricular morphology. Arterial vascular patency was
confirmed by fluoroscopy (n = 2), with opacification of ECA, PAA
and STA axis and their distal parenchymal branches, without signs
of intra-graft contrast extravasation (Fig. 1E, Supplementary Video
1). Venous outlet couldn’t be assessed with this analysis: the liquid
drops observation only reflected the quality of the venous vascular
control at graft section, more difficult in decellularized ears, with
however no impact on the quality of the decellularization and
the patency of the vascular tree; the venous obstruction, correlated
to parenchyma edema formation, was very limited. Regarding MAP
evolution during protocol, SDS perfusion was associated with an
important increase of arterial vascular resistances, macroscopically
associated with edema of the fat layer; MAP decreased as steps
were followed, and finally came back to initial MAP value after
decellularization completion (Fig. 1F).
Supplementary Video 1.
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H&E and DAPI confirmed cellular clearance in skin and adnexa,
with a few remnant chondrocyte nuclei visible in the deep carti-
lage, associated with negativity of type I MHC markers in treatedFig. 1. Cadaveric ear graft perfusion-decellularization. A Native ear flap after procure
superficial temporal artery STA) and venous (external jugular vein EJV) pedicle, with a
Perfusion-decellularization: left, after 24 h perfusion, with evidence of epidermolysis an
(left) and posterior (right) views, with evidence of morphology preservation and oil cysts
section and staining with type IV Sudan fat staining prior (up) and after (down) polar solv
PAA are opacified. F Mean arterial pressure (MAP) evolution during process (n = 4), at cgrafts (Fig. 2A–C). The complete nuclei clearance could be observed
already before DNAse perfusion (see Supplementary material 2).
CD31 markers of endothelial cells were also completely removed
(Fig. 2D). DNA quantifications in D-Skin, D-Fat and D-Cartilage
were found to be respectively 0.99 ± 0.75, 0.84 ± 0.56 and
4.82 ± 3.95 ng/mg wet weight compared to 88.7 ± 9.6, 28.2 ± 15.7
and 121.7 ± 31.1 ng/mg wet weight in native samples; this repre-
sented an overall 97.3% DNA reduction in HE-ECM (p < 0.001)
(Fig. 2E).3.3. ECM preservation
3.3.1. Histology
MT, type I and type II collagen stains confirmed the high-quality
preservation and structural organization of major collagen proteins
(Fig. 3A–C). Type IV collagen, which is fundamental for basal mem-
branes and critical for further epidermal reconstruction strategies,
was well-observed in the vessels, glands and especially in the der-
mis, at the level of the dermo-epidermal junction (DEJ) (Fig. 3D).
Alcian blue and safranin O stains demonstrated GAG preservation
in the cartilage layer, with some reduction in peripheral areas more
exposed to the decellularizing flow agents through the perichon-
drium (Fig. 3E and F).ment, with arterial (external carotid artery ECA, posterior auricular artery PAA,
nterior (left) and posterior (right) views; the arrow indicates the flow direction. B
d large bullae formation (arrows); right, final aspect. C Decellularized ear anterior
removal, after 2-propanol solvent treatment. GAN Great Auricular Nerve. D Ear lobe
ent treatment. Scale bars 1 mm. E Arterial fluoroscopy of decellularized ear: STA and
onstant output. MAP expressed in mm Hg.
Fig. 2. Cells and antigens removal. A H&E staining comparing native (left) and decellularized (right) ear grafts. E epidermis, D dermis, PC perichondrium, C cartilage. Inserts
show magnified details (black squares) of the section. B DAPI staining showing native (left) and decellularized (right) ear sections. C anti-type I HLA staining in native (left)
versus decellularized (right) tissues. D Anti-CD31 staining in native (left) versus decellularized (right) tissues. E DNA content in native (N-) versus decellularized (D-) tissues,
expressed in ng/mg wet weight. Analysis performed on skin (n = 6), fat (n = 4) and cartilage (n = 3) samples from native ear (n = 3) and HE-ECM (n = 3). Statistics were
performed using unpaired student t-test, mean ± SEM, ***p < 0.001, **p < 0.01, *p < 0.05. Scale bars: upper raw, 1 mm for the section overview, 200 mm for the inserts; lower
raw 100 mm.
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ultrastructure with dermal papillae, cartilage with emptied chon-
drocyte lacunae, and fat with fibrillary organization and absence
of oil cysts. No detergent crystal could be detected in examined
samples, revealing the efficiency of PBS perfusion to remove them
(Fig. 3G–J).
3.3.2. ECM protein quantification
The qualitative ECM assessment was correlated to the preserva-
tion of its major protein content (Fig. 3K–M). Collagen was
highly preserved in D-Skin, D-Fat and D-Cartilage (87.2 ± 14.3,
126.5 ± 52.5 and 36.7 ± 12.3 lg per mg wet weight respectively)
compared to controls (20.3 ± 8.2, 41.2 ± 23.2 and 21 ± 8 lg per
mg wet weight respectively), representing a mean relative increase
in collagen content of 300% compared to native tissues. The global
content increase is explained by collagen preservation following
perfusion-decellularization, as well as by the reduction of cell con-
tent and other ECM proteins, leading to an important relative mass
increase in all ear scaffold tissues. Mean elastin content in D-Skin,
D-Fat and D-Cartilage was 4.96 ± 1.5, 3.96 ± 0.99 and 13.64 ± 1.8 lg
per mg wet weight respectively, compared to 16.68 ± 4.41,
14.53 ± 6.44 and 14.98 ± 6.92 lg per mg wet weight respectivelyin controls. Reduction of elastin was significant in skin (p < 0.05),
with 41.3% relative preservation of elastin content while in
cartilage 82% of native elastin content was preserved with non-
significant difference. For GAGs, D-Skin, D-Fat and D-Cartilage was
0.2 ± 0.1, 0.33 ± 0.01 and 2.82 ± 1.2 lg per mg wet weight respec-
tively, compared to 0.53 ± 0.01, 0.47 ± 0.11 and 7.23 ± 0.65 lg per
mg wet weight respectively in controls. D-Skin preserved 42.6% of
native GAG content while GAG value represented 40% of native con-
tent preservation for D-Cartilage (p < 0.05). It is vitally important
that both elastin and collagen content are preserved in cartilage,
as they are primarily responsible for the mechanical properties of
cartilage: indeed, preservation of the morphological support is
one of the most important feature for auricular graft functionality.
3.3.3. The tridimensional structural preservation
The tridimensional structural preservation of specific elements
of the composite tissue is appreciated (elastin, collagen, GAGs),
by the 3D-ECM histological reconstructions. From these samples,
we extracted a volume of subunits for 3D reconstructions
(Fig. 4A and B), enabling a better targeted structural assessment.
The 3D cartilage subunit evaluation confirmed the 2D histology
observation and quantification, with a better characterization of
Fig. 3. ECM major proteins and 2D structure preservation. A–F Histology stainings by AMasson’s trichrome of skin, B Type I collagen of skin, C type II collagen of cartilage, D
type IV collagen in dermis, E Alcian blue and F Safranin O in cartilage, of native (upper raw) and decellularized (lower raw) tissues; DEJ, dermo-epidermal junction. G-J SEM
evaluation of G dermal surface with preserved dermal papillae (DP),H dermal section with appreciation of DEJ, I cartilage section and J adipose tissue, from acellular scaffolds;
insert represent native samples. K-M Major ECM content quantification: K Collagen, L Elastin and M GAGs; expressed in mg/mg wet weight of tissue. Analysis performed on
skin (n = 6), fat (n = 4) and cartilage (n = 3) samples from native ear (n = 3) and HE-ECM (n = 3) Statistics were performed using unpaired student t-test, mean ± SEM, **p <
0.01, *p < 0.05. Scale bars: 100 mm. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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skin, the 3D volume confirmed the presence of intact dermal
papillae and adnexal removal. The connective tissue, including
deep dermis, adipose tissue, vessels and glands appeared at a lesser
density. On the 3D volumes quantification, the porosity of whole-
biopsy volume was increased in the decellularized sample, with a
mean non-stained ratio to stained areas of 32.2 ± 2.2%, compared
to 20.8 ± 2.6% in the native sample (Fig. 4C). When excluding the
cartilage, the porosity in HE-ECM was even higher, with 46%,signifying the loss of structural volumes mainly located in the
non-cartilaginous areas.3.3.4. Mechanical properties
Ball burst testing of cartilage revealed an overall reduction of
stiffness in decellularized (9.3+/8.4 N/mm, range 1.5–21.3) com-
pared to native samples (18.4+/9.3 N/mm, range 4.4–30.2). This
result demonstrates an overall reduction of the stiffness in the
Fig. 4. ECM 3D-histology reconstruction. A Methodology: native and decellularized ear samples are serial sectioned, then digitalized and treated for 3D alignment and
reconstruction with a specific software. 2D/3D scale bars: 1 mm. B Biopsy location (left), 3D-histology volume reconstruction and virtual sampling locations (middle) for 3D
subunit elementary tissue reconstruction: connective tissue, cartilage and skin, from native and decellularized samples (right). 3D Scale bars: 75 lm. C Porosity value
calculated from the ratio between non-stained and stained area in the whole 3D biopsy volume from native and decellularized samples, with inclusion of cartilage layer.
J. Duisit et al. / Acta Biomaterialia 73 (2018) 339–354 347decellularized group, remaining however in the same order of
magnitude as for the native.
Tensile testing of skin showed an increase in maximum
engineering stress after decellularization, along with an increase
in dispersion of maximum stress (0.9+/0.4 MPa for native tissues
versus 1.2+/0.6 MPa for decellularized tissues). Strain at
maximum stress was not significantly different between native
(0.4+/0.1 MPa) and decellularized (0.4+/0.2 MPa) tissues (See
Supplementary material 3, skin stress-strain curves).
3.4. HE-ECM preservation of cytokines
The cytokine analysis revealed that essentially all 42 tested
cytokines were measurable in skin, cartilage and fat samples. In
order to quantitatively characterize cytokine preservation in the
different tissues of the scaffold, we analyzed the degree of change
of growth factors in each biological sample. As shown (Fig. 5A), all
the measured cytokines in skin samples collected from the
decellularized scaffold decreased significantly compared to native
skin samples. Conversely, none of the measured cytokines
decreased significantly by decellularization in fat tissue, with the
exception of IL-4 which was below detection level. Cartilage pre-sented a middle behavior with 22/44 cytokines significantly
decreased after decellularization compared to controls. To better
understand how the decellularization process affected cytokines
in HE-ECM, we calculated the relative proportion of preservation
for each cytokine in decellularized tissues expressed as percentage
of the native mean abundance (Fig. 5B). In order to investigate
whether different cytokine subclasses were differentially affected
by the decellularization process, the following cytokine groups
were created according to cytokine function: 1) pro-
inflammatory cytokines (IL-1b, IL-6, IFNc, TNF-a, MIF), 2)
Chemokines (IL-16, CCL1, CCL2, CCL3, CCL7, CCL8, CCL11, CCL13,
CCL15, CCL17, CCL19, CCL20, CCL21, CCL22, CCL23, CCL24, CCL25,
CCL26, CCL27, CXCL1, CXCL2, CXCL6, CXCL9, CXCL10, CXCL11)
and 3) Growth factors (IL-2, IL-4, IL-8, IL-10, GM-CSF, TGF-b1,
TGF-b2, TGF-b3, CXCL5, CXCL12). Although many cytokines exhibit
pleiotropy, we classified each cytokine into one of the three groups.
No double classifications were allowed. As shown (Fig. 5C), in
decellularized skin total protein preservation was 8.75 ± 4.07%
with similar preservation of pro-inflammatory cytokines and
chemokines (5.88 ± 5.0% and 7.13 ± 7.87%, respectively). Growth
factors showed a much higher percentage of preservation (152.6
8 ± 213.84) compared to pro-inflammatory cytokines and chemo-
Fig. 5. Cytokines quantification. A Heatmap showing changes in abundances of 42 absolutely quantified cytokines in skin, fat and cartilage biopsies from four native (N-) and
three decellularized (D-) scaffolds. Individual protein pictogram abundance per milligram of tissue was log2 transformed. Yellow boxes correlate with lower protein
concentration and red boxes with higher protein concentration (see scale). Crossed boxes indicate samples under the detection limit. *p < 0.05; **p < 0.01; ***p < 0.001; ****p <
0.0001 by two-sample t-tests with Benjamini, Krieger and Yekutieli correction to compare native and decellularized values. B Heatmap showing cytokine preservation after
decellularization in skin, fat and cartilage as percentage of native tissues abundance. White boxes correlate with lower preservation and blue boxes with higher cytokine
preservation. Purple boxes indicate increased cytokine levels as compared to native tissues (100%). C Relative preservation of total protein extract (grey), pro-inflammatory
cytokines (yellow), chemokines (green) and growth factors (blue) in decellularized skin, fat and cartilage. Highly preserved cytokines (>100%) are indicated. Data presented as
mean ± SD. *p < 0.05; ***p < 0.001 by one-way ANOVA with Tukey’s correction. (For interpretation of the references to color in this figure legend, the reader is referred to the
web version of this article.)
348 J. Duisit et al. / Acta Biomaterialia 73 (2018) 339–354kines. Similar results were observed in cartilage (41.99 ± 6.73%, 19.
48 ± 11.21%, 17.30 ± 11.53% and 78.77 ± 80.37 of preservation of
total protein, pro-inflammatory cytokines, chemokines and growth
factor, respectively) and in fat (12.9 ± 5.09%, 31.74 ± 21.65%, 43.63
± 33.52%, 255.94 ± 275.28% of preservation of total protein, pro-
inflammatory cytokines, chemokines and growth factor, respec-
tively). Interestingly, only three of the forty-two cytokines (i.e.,
TGF-beta1, TGF-beta3 and CXCL5) showed an increase in expres-
sion levels when comparing decellularized and native tissues. This
is likely due to more efficient protein extraction in the cell-empty
ECMS and the increase in the ratio of pg cytokine per total ECMS
weight in the decellularized tissues. In fat tissue, three cytokines
displayed relative increase as compare to native tissue (i.e., IL-2,
CXCL2 and CCL24), confirming the higher capacity of the adipose
tissue to retain growth factors during the decellularization process.
Apart from TGF-b1, TGF-b3 and CXCL5 the most preserved cytoki-
nes across tissues were IL-2, GM-CSF, CCL1, CCL24 and CXCL2
(Fig. 5B).
3.5. In vivo implantation – Biocompatibility study
There was no adverse event encountered at the time of graft
implantation. During scaffold retrieval, the surrounding abdominal
wall skin appeared healthy, and after incision and direct implant
observation, no obvious capsular formation could be identified.
The integration with recipient tissues was satisfying in all groups
with signs of macroscopic vascular infiltration present. At histol-
ogy, the cellular infiltration was diffuse at POD15 and POD30,
but less important at POD60, with signs of micro-vascular perme-ability in the deep scaffold (Fig. 6A), compared to the native control
(Fig. 6A and B), even the difference was not as strong as expected,
due to the sterilization protocol. Remodeling was globally limited.
CD68 + macrophage infiltration was significant and located exclu-
sively within the scaffold, being less intense and more peripheral
at POD60 (Fig. 6C–F); this correlates to the CD68 staining quantifi-
cation, in which the % stained area was significantly (p < 0.0001)
higher in the control native group at POD15, with reduction at
POD30 so that there was now no difference between groups. At
POD60, the native group was significantly more infiltrated than
the decellularized group (**p < 0.001). Interestingly, the decellular-
ized group was significantly less infiltrated at POD60 compared to
the same group at POD30 (Fig. 6G). Regarding qualitative and
quantitative anti-CD3 staining, response was found very poor, in
both native and decellularized samples, mainly located at the sur-
face of the scaffolds, and without great difference between groups.
Flow cytometry of circulating rat anti-human IgG antibodies
showed the following positive recipient immunization: 2/3
POD15 and POD30, 2/2 POD60 in control group, compared to 0/3
POD15, 1/3 POD30 and 0/2 POD60 (Fig. 6H, see Supplementary
material 4).
3.6. In vitro compatibility
For rASCs-seeded scaffolds, MTT staining revealed homoge-
neous engraftment of viable cells on all scaffolds. On the full-
thickness scaffolds, cells were located on all tissue layers including
the epidermal side (Fig. 7A–C). Cell viability was confirmed by live/
dead staining, with a few dead cells identified (Fig. 7D–F).
Fig. 6. In vivo study, subcutaneous implantation in rat. A and BMacroscopic assessment: A HE-ECM implant at time of explantation, external aspect (left) and section aspect
(right) integration between layers of skin (S) and muscle (M) of the recipient’s abdominal wall, with no signs of capsular formation and evidence of growing vessels (arrows);
B Comparison with native control with more although limited peripheral reaction (left) and absence of neo-vessels at section inspection (right); C-D HE-ECM Masson’s
trichrome assessment at C postoperative day POD15 and D POD60, with diminution of cellular infiltration, limited remodeling and patent blood vessels (arrows in D insert). M
Muscle. E-F Macrophage infiltration CD68 IHC staining at E POD15, F POD60; windows enlarged views in the inserts. G CD68 quantification at POD15, POD30 and POD60 in
native (black) and decellularized (grey) implants; H-I Lymphocyte infiltration CD3 IHC staining at H POD15, I POD60; windows enlarged views in the inserts. J CD3
quantification at POD15, POD30 and POD60 in native (black) and decellularized (grey) implants; K Flow cytometry of anti-human circulating IgG antibodies in the rat
recipient at D0 (green curve) and POD60 (purple curve), in native (above) and decellularized (below) recipients. Selected curves originate from the most representative
positive (control) and negative (decellularized) flow cytometries (for complete data set, see supplementary Fig. 3). *p < 0.05; **p < 0.001; ****p < 0.0001. Scale bars: 1 mm in
overview section, 200 lm in inserts. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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No sign of contamination was recorded during the experiment.
At retrieval, the cultured HE-ECM appeared diffusely pink, indicat-
ing perfusion and impregnation of the culture medium (Fig. 8A–C).CD31 staining was positive (to be compared with Fig. 2D) on the
endothelial wall of vessels from various calibers, found both in
superficial and deep part of the scaffold. Live/dead staining show
intra-vascular distribution of living cells, in small and larger
vessels (Fig. 8). However, no cell nuclei could be observed with
Fig. 7. In vitro compatibility. Static seeding with rat adipose-derived Stem Cells (ASC) 3.6  104 cells/cm2 for 14 days: A–C Seeded scaffold and enlarged view, and observation
of MTT staining, D–F Live/dead vital staining examination on whole-mount, of arterial pedicle (upper raw), dermis (middle raw) and full-thickness (lower raw) samples from
HE-ECM; D dermis, C cartilage. Scale bars: 1 mm.
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vessels endothelial surface (see Supplementary Fig. 5). Finally,
whole-mount MTT vital staining allow to appreciate the seeding
cover, even if segmental, of the scaffold vascular tree (Fig. 8F).
4. Discussion
A functional, implantable and clinically applicable engineered
auricle is our ultimate objective. This study takes important steps
in achieving this goal. We were able to produce whole acellular
human ears with route for access to the vascular tree utilizing
the approach of Vascularized Composite tissue Engineering. We
demonstrated that early findings from porcine ear engineering
[18] could be applicable to a human auricular graft model, confirm-
ing the relevance of the pig model in a preclinical experimental
approach for composite tissue engineering. The feasibility of using
elderly postmortem human donors, even several days after death,
was shown. This is possible because of high collagen content of
composite tissue ECM that seems to better handle cell necrosis
and proteolytic enzymes, likely due to the presence of cell popula-
tions with low metabolic activity and less aggressive enzymaticcontent, as compared to exocrine pancreas cells involving complex
organ engineering challenges [27]. Finally, vascular tree patency
was displayed at all levels throughout the auricular ECM scaffold.
It is however important to highlight that a diseased vascular tree,
with extensive arteriosclerosis, can compromise perfusion and
thus success in the decellularization.
An important difference when comparing the present data with
our porcine ear study concerned the adipose tissue defatting: the
ability to remove nuclei was efficient with detergents, as confirmed
by DAPI staining, but a high content of scattered oil cysts persisted,
requiring an additional treatment with polar solvent, as recom-
mended in non-perfused isolated human adipose tissue engineer-
ing [22]. Our polar solvent step resulted in successful fat removal,
although DAPI staining showed nuclei removal prior to the step,
without impairment of the vascular tree. Even if considered as a
minor issue for organ bioengineering, the ability to completely treat
the adipose tissue is critical when dealing with composite tissue
engineering, as fat represents a major component for this type of
graft, in both qualitative and quantitative aspects. The real question
however is whether adipose tissue needs to be fully treated or not,
as the use polar solvent is not straightforward. When considering
Fig. 8. Whole-ear scaffold perfusion-bioreactor seeding. A Perfusion-sterilization with 0.1% peracetic acid and PBS rinsing. B Sterile mounting in perfusion-bioreactor, and
immersion with culture medium, prior to cell seeding C Ear graft scaffold at time of retrieval, with pinky aspect as sign of proper culture medium perfusion and ECM
impregnation. D CD31 staining positivity (arrows), in deep (left) and superficial (right) scaffold structure. E-FWhole-mount staining and direct microscope observation after
E Live/dead and F MTT vital stainings. Scale bars: 200 mm, with exception of MTT observation with microscope 10x magnification: 1 mm.
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icant inflammatory reaction that may be deleterious to scaffold
implantation. Moreover, even for in vitro application only, native
adipose tissue persistence results in reduced engraftment of newadipocyte and thus poorer adipose tissue regeneration [23]. This
illustrates the need for combination of decellularizing agents in
VCE. Indeed, other tissues were successfully treated, with only
some donor cells observed in the cartilage. These few remaining
352 J. Duisit et al. / Acta Biomaterialia 73 (2018) 339–354cells should not be an issue considering the significant reduction of
total DNA observed in this tissue and its poor immunogenicity due
to its avascular nature and ECM density [15].
Following processing, the auricular ECM structural components
and 3D organization were well-preserved, which is critical for body
parts in which function is directly related to the preservation of its
form. The stiffness of the decellularized cartilage was maintained
in an acceptable manner in our study, which applies directly to
the target function of shape preservation of TE auricles, but may
not be universally applicable to other tissue such as knee articular
cartilage which experiences repetitive strain as its main function.
Due to the cadaveric origin and the variability of the donors in this
study, such results provide an overall appreciation of such an
assessment. In order to further determine the structural organiza-
tion of the auricular VCE, we performed a 3D characterization. This
innovative tool brings a new level of resolution to scaffold analysis,
allowing for precise comprehension of the spatial organization of
both native and decellularized tissue with accurate reproduction
of ECM in tissue engineering. As a quantitative measurement,
porosity was calculated based on 3D volume, which is a more accu-
rate assessment than conventional 2D analysis can provide. Still,
new 3D analytic tools need to be developed for soft tissue and
organ engineering evaluation, so as to mimick the success of 3D
bone tissue evaluation [28].
Perfusion-decellularization with SDS-based protocol seems to
be suitable for protection of innate cytokines of skin, fat and carti-
lage in the human ear. We showed that cytokines of different func-
tion and nature are preserved to a measurable extent. Overall,
growth-inducing cytokines were preserved most frequently, fol-
lowed by the cell-guiding chemokines then inflammatory cyto-
kines. It has been previously demonstrated that growth factors
such as TGF-b, VEGF, and bFGF are present in acellular ECM scaf-
folds, and these growth factors retain most of their biologic activity
following decellularization of the ECM and therefore may con-
tribute to the favorable characteristics of decellularized ECM scaf-
folds [29–32]. In our study we demonstrate a better preservation of
‘‘protective” growth factors and a more pronounced depletion of
pro-inflammatory cytokines across all analyzed tissues. In addition
to the positive cytokine profile, we also observed distinct responses
to the perfusion process of individual tissue ECMs in terms of pro-
tein preservation, with cartilage and fat being the most preserved
tissues. Taken together, these findings suggest that newly coloniz-
ing cells in the ECM scaffold may benefit of the presence of pre-
served growth factors bounded to the ECM and that ECM
obtained via perfusion-decellularization are therefore very likely
to increase the success rate of cell-reseeding. However, in this
study we did not assess the biological activity of the measured
cytokines. Considering the nature of the decellularization protocol
it is possible that not all the measured cytokines will be biologi-
cally active and some of themwould be in a denatured and inactive
form. It cannot be rule out that these denatured cytokines may
stimulate immune response against the scaffold. Future studies
are warranted to assess the how the specific components (both
structural and soluble) retained within an ECM scaffolds may acti-
vate the immune response and to verify whether, as recently pro-
posed, acellular ECM scaffolds may modulate the host immune
response towards a functional tissue replacement outcome [32].
We observed an overall increase of vascular resistances during
scaffold production, especially during SDS perfusion. This phe-
nomenon of increasing vascular pressure during perfusion-
decellularization has been described for other organs [17,33] with
a subsequent decrease in resistance after re-endothelialization. In
contrast to these findings, MAP was already back to normal values
after PBS rinsing in our study. Considering adaptation of perfusion
inflow, we question the need to adapt flow to follow constant ideal
vascular resistance, as recommended for solid organs preservationand engineering. Indeed, during the initial steps, a high pressure
increases the risk of damage to microcirculation and of edema for-
mation. Furthermore, vascular resistances after cellular depletion
likely reflect extra-vascular rigiditywith subsequent increasedpres-
sures against flow. Thus, maintaining adequate flow, against
increased vascular resistances, should be the goal to allow distal
perfusion.
During the in vivo part of our study, the decellularized scaffolds
were well tolerated even when significant remodeling was
observed, with an important CD68 + macrophage infiltration dur-
ing the first 8 weeks post-implantation. This remodeling is well-
known [34,35] and part of a necessary integration period of the
ECM by the recipient, with a related ECM mass decrease. In our
study, we observed a preservation of the ECM structure at
POD60, with less remodeling than expected for an ECM rich in col-
lagen. The discrepancies observed when screening anti-donor cir-
culating IgG may rely on the immunogenicity of the treated ECM
itself, along with the use of cadaveric donors. For the control, the
immune response was mild, explained by the need to use non-
fresh controls from human cadavers, with reduced allogenic prop-
erties. This was even more obvious on the anti-CD3 qualitative and
quantitative assessments, with a very light difference between
decellularized and native groups. Moreover, the need to sterilize
native tissues with 0.1% PCA participated in reducing allogenicity
further, as PCA itself has been described as a decellularizing agent
on its own [36]. This illustrates the need in such studies to use
more sophisticated techniques as FACS and antibody detection,
to draw conclusions about immune response. This appears to be
the downside of using human grafts from cadaveric sources, and
further studies should investigate the effect of procurement delay
and conditions on the overall outcome and immune response
in vivo. Nevertheless, this model is a very useful tool to study
and establish VCE protocols at a direct human scale, with readily
accessible donor supply.
When dealing with future whole-graft scaffold recellulariza-
tion strategies, it is of paramount importance to consider the
ear as a complex 3D anatomical structure at all scales, with mul-
tilayered tissues including skin, cartilage, fat, nerves and blood
vessels. This conceptual framework highlights the challenges of
creating a clinically useful auricle graft based on conventional
TE approaches, to provide the expected complexity of the living
associated to a transplantable vascular tree, to allow the survival
of the engineered ear. Even if we had an efficient protocol read-
ily available to adequately treat all the tissues at once to pro-
duce a decellularized ECM scaffold with a single vascular
access, recellularization remains an important problem to solve.
As demonstrated in this study, vascular access to facilitate seed
dissemination and preservation of basal membranes are prereq-
uisite factors to allow dermal perfusion of culture medium with
subsequent cell engraftment; non-perfused TE skin construct
approaches are limited in their ability to recellularize a scaffold
[37]. Apart from skin and vessels, which can be approached in a
direct manner for seeding, other tissue types, such as cartilage
and adipose, are buried deep in the scaffold, making it almost
impossible for any selective seeding like topical, vascular injec-
tion, or cell infusion. For these tissues, the ideal option relies
on a single-type stem cell approach, that differentiates and repli-
cates when in contact with specific ECM tissues, as demon-
strated by other groups [38,39]. For the cartilage, combined to
a whole composite scaffold, like ear or nose, the difficulty will
be important, by its deep location it the graft and the absence
of vascular access. The current strategies in cartilage engineering
have successfully treated isolated scaffolds [7,40], but cannot be
directly applied to our cadaveric auricular ECM scaffold model at
this time. Perichondrium and peripheral cartilage enhanced
porosity could allow seeded cells to repopulate the decellular-
J. Duisit et al. / Acta Biomaterialia 73 (2018) 339–354 353ized cartilage adequately with further research efforts. The dif-
ferent whole-ear bioreactor seeding experiments we performed
showed that the step of cadaveric human ear recellularization
step can be reach with our current approach; we still need to
improve the cell choices, the cells engraftment strategies, relying
on perfusion-seeding methodology as well as the number of cells
available in vitro. Regarding, this last point, we already know
that, even for such a small graft, the number of cells needed will
be prohibitive; the most pertinent strategies will be very likely
to combine partial in vitro seeding and in vivo maturation of
the scaffold. For all these reasons, the main key to success is
the long-term vascular reperfusion in a recipient, a shared limi-
tation with parallel organ bioengineering strategies. But once a
reliable vascular regeneration methodology will be available,
the clinical applications, especially in a study already at the scale
of human grafts, will be straight-forward.5. Conclusions
Complex auricular scaffolds with preserved vasculature can be
obtained from human delayed postmortem sources to provide a
platform for further functional tissue engineered constructs. Access
to an auricular vascular tree, for which preservation and accessibil-
ity has been obtained for the first time in this study, is the key step
required to translate experimental science to clinical usage. Over-
all, perfusion-decellularization application to body parts show
great promise in generating suitable composite tissue scaffolds
for body reconstruction. The goal of future experiments should
be to improve the efficiency of the decellularization protocol and
to improve recellularization by enhancing vascular seeded engraft-
ment and density, as well as epidermal regeneration on a perfused
acellular dermis.Author contributions
JD designed study, performed all procurements, set up and per-
formed all decellularizations and scaffolds seeding, interpreted
data, wrote article. HA and DA participated extensively to speci-
men collection and treatment, performed analysis. TW, AT, EV
and RR performed all cytokines quantifications. CBo performed
all histological processing and quantifications. DM was responsible
for 3D histology reconstruction and quantification. VD and PD per-
formed all mechanical testings. DH and GO participated to study
design and data interpretation. CBe, PG and BL participated to
study design, supported all analysis. All authors interpreted data,
revised manuscript and gave their final approval.Acknowledgments
The authors express gratitude to Erick Montoya, An Catherine
Hoang Le Thien, Sarah El Hathout, Daela Xhema, Marc de Bournon-
ville, Darren Treanor, Chantal Fregimilicka, Michele De Beukelaer,
Christine de Ville de Goyet, Marie Henry, Bernard Caelen, Pascale
Segers and Walter Hudders for their devoted technical assistance
or logistic support. Finally, the authors thank Alain Despont for
his valuable and extensive support for the Luminex assay.Conflict of interest/disclosure
HG-MIM Software is produced by HeteroGenius Limited, UK, of
which Derek Magee is a director. All authors approved the final
version of the article.Funding source
This work was supported by a Fondation Saint-Luc Grant,
FSR-UCL (Fonds Spécial de la Recherche) and Fonds Dr. Gaëtan
Lagneaux.Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at https://doi.org/10.1016/j.actbio.2018.04.009.References
[1] F. Firmin, A. Marchac, A novel algorithm for autologous ear reconstruction,
Semin. Plast. Surg. 25 (2011) 257–264.
[2] L. Kasrai, A.K. Snyder-Warwick, D.M. Fisher, Single-stage autologous ear
reconstruction for microtia, Plast. Reconstr. Surg. 133 (2014) 652–662.
[3] S. Nagata, A new method of total reconstruction of the auricle for microtia,
Plast. Reconstr. Surg. 92 (1993) 187–201.
[4] N. Baluch, S. Nagata, C. Park, G.H. Wilkes, J. Reinisch, L. Kasrai, D. Fisher,
Auricular reconstruction for microtia: a review of available methods, Plast.
Surg. (Oakv.) 22 (2014) 39–43.
[5] J.P. Giot, D. Labbe, E. Soubeyrand, R. Pacini, M.R. Guillou-Jamard, J.F. Compere,
H. Benateau, Prosthetic reconstruction of the auricle: indications, techniques,
and results, Semin. Plast. Surg. 25 (2011) 265–272.
[6] B.G. Lengelé, Current concepts and future challenges in facial transplantation,
Clin. Plast. Surg. 36 (2009) 507–521.
[7] Y. Cao, J.P. Vacanti, K.T. Paige, J. Upton, C.A. Vacanti, Transplantation of
chondrocytes utilizing a polymer-cell construct to produce tissue-engineered
cartilage in the shape of a human ear, Plast. Reconstr. Surg. 100 (1997) 297–
302.
[8] H.W. Kang, S.J. Lee, I.K. Ko, C. Kengla, J.J. Yoo, A. Atala, A 3D bioprinting system
to produce human-scale tissue constructs with structural integrity, Nat.
Biotechnol. 34 (2016) 312–319.
[9] T.M. Cervantes, E.K. Bassett, A. Tseng, A. Kimura, N. Roscioli, M.A. Randolph, J.P.
Vacanti, T.A. Hadlock, R. Gupta, I. Pomerantseva, C.A. Sundback, Design of
composite scaffolds and three-dimensional shape analysis for tissue-
engineered ear, J. R. Soc. Interface 10 (2013) 20130413.
[10] H.C. Ott, B. Clippinger, C. Conrad, C. Schuetz, I. Pomerantseva, L. Ikonomou, D.
Kotton, J.P. Vacanti, Regeneration and orthotopic transplantation of a
bioartificial lung, Nat. Med. 16 (2010) 927–933.
[11] H.C. Ott, T.S. Matthiesen, S.K. Goh, L.D. Black, S.M. Kren, T.I. Netoff, D.A. Taylor,
Perfusion-decellularized matrix: using nature’s platform to engineer a
bioartificial heart, Nat. Med. 14 (2008) 213–221.
[12] G. Orlando, A.C. Farney, S.S. Iskandar, S.H. Mirmalek-Sani, D.C. Sullivan, E.
Moran, T. Aboushwareb, P. De Coppi, K.J. Wood, R.J. Stratta, A. Atala, J.J. Yoo, S.
Soker, Production and implantation of renal extracellular matrix scaffolds
from porcine kidneys as a platform for renal bioengineering investigations,
Ann. Surg. 256 (2012) 363–370.
[13] G. Orlando, S. Soker, R.J. Stratta, Organ bioengineering and regeneration as the
new Holy Grail for organ transplantation, Ann. Surg. 258 (2013) 221–232.
[14] B.E. Uygun, G. Price, N. Saedi, M.L. Izamis, T. Berendsen, M. Yarmush, K. Uygun,
Decellularization and recellularization of whole livers, J. Vis Exp. (2011).
[15] N. Hou, P. Cui, J. Luo, R. Ma, L. Zhu, Tissue-engineered larynx using perfusion-
decellularized technique and mesenchymal stem cells in a rabbit model, Acta
Otolaryngol. 131 (2011) 645–652.
[16] R. Ma, M. Li, J. Luo, H. Yu, Y. Sun, S. Cheng, P. Cui, Structural integrity, ECM
components and immunogenicity of decellularized laryngeal scaffold with
preserved cartilage, Biomaterials 34 (2013) 1790–1798.
[17] B.J. Jank, L. Xiong, P.T. Moser, J.P. Guyette, X. Ren, C.L. Cetrulo, D.A. Leonard, L.
Fernandez, S.P. Fagan, H.C. Ott, Engineered composite tissue as a bioartificial
limb graft, Biomaterials 61 (2015) 246–256.
[18] J. Duisit, G. Orlando, D. Debluts, L. Maistriaux, D. Xhema, Y.A. de Bisthoven, C.
Galli, A. Peloso, C. Behets, B. Lengelé, P. Gianello, Decellularization of the
porcine ear generates a biocompatible, nonimmunogenic extracellular matrix
platform for face subunit bioengineering, Ann. Surg. 266 (2017) 754–764.
[19] J. Duisit, L. Maistriaux, A. Taddeo, G. Orlando, V. Joris, E. Coche, C. Behets, J.
Lerut, C. Dessy, G. Cossu, E. Vögelin, R. Rieben, P. Gianello, B. Lengelé,
Bioengineering a human graft: the matrix of Identity, Ann. Surg. (2017) [Epub
ahead of print].
[20] B.G. Ulusal, A.E. Ulusal, J.Y. Lin, B.K. Tan, C.H. Wong, C. Song, F.C. Wei,
Anatomical and technical aspects of harvesting the auricle as a neurovascular
facial subunit transplant in humans, Plast. Reconstr. Surg. 120 (2007) 1540–
1545.
[21] J. Duisit, H. Amiel, D. Debluts, L. Maistriaux, A. Gerdom, A. Bol, P. Gianello, C.
Behets, B. Lengelé, Single-artery human ear graft procurement: a simplified
approach, Plast. Reconstr. Surg. 140 (2017) 599–603.
[22] L.E. Flynn, The use of decellularized adipose tissue to provide an inductive
microenvironment for the adipogenic differentiation of human adipose-
derived stem cells, Biomaterials 31 (2010) 4715–4724.
354 J. Duisit et al. / Acta Biomaterialia 73 (2018) 339–354[23] L. Wang, J.A. Johnson, Q. Zhang, E.K. Beahm, Combining decellularized human
adipose tissue extracellular matrix and adipose-derived stem cells for adipose
tissue engineering, Acta Biomater. 9 (2013) 8921–8931.
[24] P. Sarathchandra, R.T. Smolenski, A.H. Yuen, A.H. Chester, S. Goldstein, A.E.
Heacox, M.H. Yacoub, P.M. Taylor, Impact of gamma-irradiation on
extracellular matrix of porcine pulmonary valves, J. Surg. Res. 176 (2012)
376–385.
[25] C.A. Schneider, W.S. Rasband, K.W. Eliceiri, NIH Image to ImageJ: 25 years of
image analysis, Nat. Methods 9 (2012) 671–675.
[26] T. Schubert, D. Xhema, S. Veriter, M. Schubert, C. Behets, C. Delloye, P. Gianello,
D. Dufrane, The enhanced performance of bone allografts using osteogenic-
differentiated adipose-derived mesenchymal stem cells, Biomaterials 32
(2011) 8880–8891.
[27] A. Peloso, L. Urbani, P. Cravedi, R. Katari, P. Maghsoudlou, M.E. Fallas, V. Sordi,
A. Citro, C. Purroy, G. Niu, J.P. McQuilling, S. Sittadjody, A.C. Farney, S.S.
Iskandar, J.P. Zambon, J. Rogers, R.J. Stratta, E.C. Opara, L. Piemonti, C.M. Furdui,
S. Soker, P. De Coppi, G. Orlando, The human pancreas as a source of
protolerogenic extracellular matrix scaffold for a new-generation bioartificial
endocrine pancreas, Ann. Surg. 264 (2016) 169–179.
[28] D. Chappard, E. Legrand, B. Haettich, G. Chales, B. Auvinet, J.P. Eschard, J.P.
Hamelin, M.F. Basle, M. Audran, Fractal dimension of trabecular bone:
comparison of three histomorphometric computed techniques for
measuring the architectural two-dimensional complexity, J. Pathol. 195
(2001) 515–521.
[29] S.L. Voytik-Harbin, A.O. Brightman, M.R. Kraine, B. Waisner, S.F. Badylak,
Identification of extractable growth factors from small intestinal submucosa, J.
Cell. Biochem. 67 (1997) 478–491.
[30] C.A. McDevitt, G.M. Wildey, R.M. Cutrone, Transforming growth factor-beta1
in a sterilized tissue derived from the pig small intestine submucosa, J.
Biomed. Mater. Res. A 67 (2003) 637–640.[31] J.P. Hodde, D.M. Ernst, M.C. Hiles, An investigation of the long-term bioactivity
of endogenous growth factor in OASIS Wound Matrix, J. Wound Care 14 (2005)
23–25.
[32] J.L. Dziki, L. Huleihel, M.E. Scarritt, S.F. Badylak, Extracellular matrix
bioscaffolds as immunomodulatory biomaterials, Tissue Eng. Part A 23
(2017) 1152–1159.
[33] J.J. Song, J.P. Guyette, S.E. Gilpin, G. Gonzalez, J.P. Vacanti, H.C. Ott,
Regeneration and experimental orthotopic transplantation of a
bioengineered kidney, Nat. Med. 19 (2013) 646–651.
[34] B.E. Uygun, A. Soto-Gutierrez, H. Yagi, M.L. Izamis, M.A. Guzzardi, C. Shulman,
J. Milwid, N. Kobayashi, A. Tilles, F. Berthiaume, M. Hertl, Y. Nahmias, M.L.
Yarmush, K. Uygun, Organ reengineering through development of a
transplantable recellularized liver graft using decellularized liver matrix,
Nat. Med. 16 (2010) 814–820.
[35] S.F. Badylak, T.W. Gilbert, Immune response to biologic scaffold materials,
Semin. Immunol. 20 (2008) 109–116.
[36] P.M. Crapo, T.W. Gilbert, S.F. Badylak, An overview of tissue and whole organ
decellularization processes, Biomaterials 32 (2011) 3233–3243.
[37] H. Bannasch, G.B. Stark, F. Knam, R.E. Horch, M. Fohn, Decellularized dermis in
combination with cultivated keratinocytes in a short- and long-term animal
experimental investigation, J. Eur. Acad. Dermatol. Venereol. 22 (2008) 41–49.
[38] S.L. Ng, K. Narayanan, S. Gao, A.C. Wan, Lineage restricted progenitors for the
repopulation of decellularized heart, Biomaterials 32 (2011) 7571–7580.
[39] L. Cui, Y. Wu, L. Cen, H. Zhou, S. Yin, G. Liu, W. Liu, Y. Cao, Repair of articular
cartilage defect in non-weight bearing areas using adipose derived stem cells
loaded polyglycolic acid mesh, Biomaterials 30 (2009) 2683–2693.
[40] I. Fulco, S. Miot, M.D. Haug, A. Barbero, A. Wixmerten, S. Feliciano, F. Wolf, G.
Jundt, A. Marsano, J. Farhadi, M. Heberer, M. Jakob, D.J. Schaefer, I. Martin,
Engineered autologous cartilage tissue for nasal reconstruction after tumour
resection: an observational first-in-human trial, Lancet 384 (2014) 337–346.
